Cargando…
The Effect of Probiotics (MCP(®) BCMC(®) Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease
Treatment for non-alcoholic fatty liver disease (NAFLD) currently consists of lifestyle modifications such as a low-fat diet, weight loss, and exercise. The gut microbiota forms part of the gut–liver axis and serves as a potential target for NAFLD treatment. We investigated the effect of probiotics...
Autores principales: | Mohamad Nor, Mohamad Hizami, Ayob, Nurainina, Mokhtar, Norfilza M., Raja Ali, Raja Affendi, Tan, Geok Chin, Wong, Zhiqin, Shafiee, Nor Hamizah, Wong, Yin Ping, Mustangin, Muaatamarulain, Nawawi, Khairul Najmi Muhammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468225/ https://www.ncbi.nlm.nih.gov/pubmed/34579068 http://dx.doi.org/10.3390/nu13093192 |
Ejemplares similares
-
The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
por: Ayob, Nurainina, et al.
Publicado: (2023) -
Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
por: Ahmad Kendong, Siti Maryam, et al.
Publicado: (2021) -
Implication of food insecurity on the gut microbiota and its potential relevance to a multi‐ethnic population in Malaysia
por: Shafiee, Nor H, et al.
Publicado: (2022) -
An assessment of dietary intake, food avoidance and food beliefs in patients with ulcerative colitis of different disease status
por: Shafiee, Nor Hamizah, et al.
Publicado: (2020) -
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
por: Shafiee, Nor Hamizah, et al.
Publicado: (2021)